Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Jonathan Dranoff

TitleProfessor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentInternal Med, College of Medicine
DivisionInternal Med Gastroenterology
Address8S 68 Shorey
324 UAMS Campus Dr.
Mail Slot # 567
Little Rock AR 72205
Phone501-686-7840
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Dr. Dranoff was raised in Philadelphia, Pennsylvania and obtained a B.A. degree from Lehigh University and M.D. from Drexel University College of Medicine. He trained in Internal Medicine at Boston University and the Boston City Hospital prior to training in Digestive Diseases at Yale University Medical School in New Haven, Connecticut. After completing his training at Yale, he remained as a faculty member there from 1999-2011. Dr. Dranoff is an internationally-known physician scientist. His clinical expertise focuses on the 'cholangiopathies', conditions primarily affecting bile duct cells, including primary biliary cirrhosis and primary sclerosing cholangitis. Dr. Dranoff also has a strong interest in cirrhosis and its complications. These clinical interests dovetail with Dr. Dranoff's NIH-supported research, focusing on the basic mechanisms of liver fibrosis and cirrhosis. AwardsPhi Eta Sigma, Lehigh University, 1987 Glaxo Institute for Digestive health Basic Science Award, 1999-2000, 2000-2001 AASLD Schering Advanced Hepatology Fellowship 2000-2001 Mt Desert Island Biological Laboratory New Investigator Award, 2000-2002 The Robert Leet and Clara Patterson Trust Basic Science Award, 2002 and 2003 GRG/AGA Young Investigator Symposium 2003 American Heart Association, Heritage Affiliate, Grant-in-aid, 2001-2007 AstraZeneca Emerging Leaders Programme, 2005-2006 American Society for Clinical Investigation, Inducted 2010


    Collapse Research Funds 
    Collapse research activities
    747-304     (DRANOFF, JONATHAN)Apr 22, 2019
    Intercept Pharmaceuticals - Pass Through: Syneos Health
    Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatophepatitis (IRB#228072)
    Role: Principal Investigator
    TARGET-PBC     (DRANOFF, JONATHAN)Mar 15, 2017
    TARGET PharmaSolutions Inc
    A 5-year Longitudinal Observational Study of Patients with Primary Biliary Cholangitis
    Role: Principal Investigator
    S10OD018065     (STORRIE, BRIAN)Jul 1, 2015 - Jun 30, 2017
    NIH
    Super-Resolution Light Microscope at University of Arkansas for Medical Sciences
    Role: Co-Investigator
    R56DK070849     (DRANOFF, JONATHAN A)Aug 1, 2010 - Jul 31, 2011
    NIH
    Pathogenesis of Biliary Cirrhosis
    Role: Principal Investigator
    R01DK076735     (DRANOFF, JONATHAN A)Apr 15, 2008 - Mar 31, 2014
    NIH
    Regulation of Hepatic Stellate Cells by Extracellular Nucleotides
    Role: Principal Investigator
    R56DK076735     (DRANOFF, JONATHAN A)Dec 1, 2006 - Aug 31, 2016
    NIH
    Regulation of hepatic stellate cells by intracellular calcium
    Role: Principal Investigator
    R01DK070849     (DRANOFF, JONATHAN A)Jun 15, 2005 - Apr 30, 2010
    NIH
    Regulation of Bile Ductular Proliferation
    Role: Principal Investigator
    R03DK066287     (DRANOFF, JONATHAN A)Jul 1, 2004 - Jun 30, 2006
    NIH
    NTPDase2 expression and function in the liver
    Role: Principal Investigator
    K08DK002739     (DRANOFF, JONATHAN A)Sep 29, 2000 - Jun 30, 2005
    NIH
    PARACRINE REGULATION OF BILE DUCT SECRETION BY ATP
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Tas E, Bai S, Ou X, Mercer K, Lin H, Mansfield K, Buchmann R, Diaz EC, Oden J, Børsheim E, Adams SH, Dranoff J. Fibroblast Growth Factor-21 to Adiponectin Ratio: A Potential Biomarker to Monitor Liver Fat in Children With Obesity. Front Endocrinol (Lausanne). 2020; 11:654. PMID: 33071964.
      View in: PubMed
    2. LoBianco FV, Krager KJ, Carter GS, Alam S, Yuan Y, Lavoie EG, Dranoff JA, Aykin-Burns N. The Role of Sirtuin 3 in Radiation-Induced Long-Term Persistent Liver Injury. Antioxidants (Basel). 2020 May 11; 9(5). PMID: 32403251.
      View in: PubMed
    3. Eubanks HB, Lavoie EG, Goree J, Kamykowski JA, Gokden N, Fausther M, Dranoff JA. Reduction in SNAP-23 Alters Microfilament Organization in Myofibrobastic Hepatic Stellate Cells. Gene Expr. 2020 06 12; 20(1):25-37. PMID: 31757226.
      View in: PubMed
    4. Hintermann E, Bayer M, Conti CB, Fuchs S, Fausther M, Leung PS, Aurrand-Lions M, Taubert R, Pfeilschifter JM, Friedrich-Rust M, Schuppan D, Dranoff JA, Gershwin ME, Manns MP, Imhof BA, Christen U. Junctional adhesion molecules JAM-B and JAM-C promote autoimmune-mediated liver fibrosis in mice. J Autoimmun. 2018 07; 91:83-96. PMID: 29753567.
      View in: PubMed
    5. Fausther M, G Lavoie E, Dranoff JA. Liver myofibroblasts of murine origins express mesothelin: Identification of novel rat mesothelin splice variants. PLoS One. 2017; 12(9):e0184499. PMID: 28898276.
      View in: PubMed
    6. Dranoff JA. Coffee Consumption and Prevention of Cirrhosis: In Support of the Caffeine Hypothesis. Gene Expr. 2018 03 21; 18(1):1-3. PMID: 28893365.
      View in: PubMed
    7. Lavoie EG, Fausther M, Goree JR, Dranoff JA. The Cholangiocyte Adenosine-IL-6 Axis Regulates Survival During Biliary Cirrhosis. Gene Expr. 2017 11 27; 17(4):327-340. PMID: 28893353.
      View in: PubMed
    8. Fausther M, Lavoie EG, Goree JR, Dranoff JA. An Elf2-like transcription factor acts as repressor of the mouse ecto-5'-nucleotidase gene expression in hepatic myofibroblasts. Purinergic Signal. 2017 Dec; 13(4):417-428. PMID: 28667437.
      View in: PubMed
    9. Manzanares MÁ, Usui A, Campbell DJ, Dumur CI, Maldonado GT, Fausther M, Dranoff JA, Sirica AE. Transforming Growth Factors a and ß Are Essential for Modeling Cholangiocarcinoma Desmoplasia and Progression in a Three-Dimensional Organotypic Culture Model. Am J Pathol. 2017 May; 187(5):1068-1092. PMID: 28315313.
      View in: PubMed
    10. Hubel E, Saroha A, Park WJ, Pewzner-Jung Y, Lavoie EG, Futerman AH, Bruck R, Fishman S, Dranoff JA, Shibolet O, Zvibel I. Sortilin Deficiency Reduces Ductular Reaction, Hepatocyte Apoptosis, and Liver Fibrosis in Cholestatic-Induced Liver Injury. Am J Pathol. 2017 Jan; 187(1):122-133. PMID: 27842214.
      View in: PubMed
    11. Li L, Piontek K, Ishida M, Fausther M, Dranoff JA, Fu R, Mezey E, Gould SJ, Fordjour FK, Meltzer SJ, Sirica AE, Selaru FM. Extracellular vesicles carry microRNA-195 to intrahepatic cholangiocarcinoma and improve survival in a rat model. Hepatology. 2017 02; 65(2):501-514. PMID: 27474881.
      View in: PubMed
    12. Klair JS, Girotra M, Dranoff JA, Aduli F. Protein Shakes: An Unusual Cause of Gastric Phytobezoar. ACG Case Rep J. 2015 Jul; 2(4):196-7. PMID: 26203434.
      View in: PubMed
    13. Feld JJ, Lavoie ÉG, Fausther M, Dranoff JA. I drink for my liver, Doc: emerging evidence that coffee prevents cirrhosis. F1000Res. 2015; 4:95. PMID: 25977756.
      View in: PubMed
    14. Fausther M, Goree JR, Lavoie ÉG, Graham AL, Sévigny J, Dranoff JA. Establishment and characterization of rat portal myofibroblast cell lines. PLoS One. 2015; 10(3):e0121161. PMID: 25822334.
      View in: PubMed
    15. Torok NJ, Dranoff JA, Schuppan D, Friedman SL. Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014. Hepatology. 2015 Aug; 62(2):627-34. PMID: 25626988.
      View in: PubMed
    16. Fausther M, Dranoff JA. Beyond scar formation: portal myofibroblast-mediated angiogenesis in the fibrotic liver. Hepatology. 2015 Mar; 61(3):766-8. PMID: 25502320.
      View in: PubMed
    17. Dranoff JA. Macrophage heterogeneity in liver injury: you are now leaving Kupffertown. Gastroenterology. 2014 Dec; 147(6):1430-1. PMID: 25457848.
      View in: PubMed
    18. Hickman DA, Syal G, Fausther M, Lavoie EG, Goree JR, Storrie B, Dranoff JA. MCP-1 downregulates MMP-9 export via vesicular redistribution to lysosomes in rat portal fibroblasts. Physiol Rep. 2014 Nov 01; 2(11). PMID: 25413315.
      View in: PubMed
    19. Goree JR, Lavoie EG, Fausther M, Dranoff JA. Expression of mediators of purinergic signaling in human liver cell lines. Purinergic Signal. 2014 Dec; 10(4):631-8. PMID: 25194703.
      View in: PubMed
    20. Fausther M, Lavoie EG, Goree JR, Baldini G, Dranoff JA. NT5E mutations that cause human disease are associated with intracellular mistrafficking of NT5E protein. PLoS One. 2014; 9(6):e98568. PMID: 24887587.
      View in: PubMed
    21. Dranoff JA, Feld JJ, Lavoie EG, Fausther M. How does coffee prevent liver fibrosis? Biological plausibility for recent epidemiological observations. Hepatology. 2014 Aug; 60(2):464-7. PMID: 24464631.
      View in: PubMed
    22. Fausther M, Dranoff JA. Integrins, myofibroblasts, and organ fibrosis. Hepatology. 2014 Aug; 60(2):756-8. PMID: 24700390.
      View in: PubMed
    23. Das M, Boerma M, Goree JR, Lavoie EG, Fausther M, Gubrij IB, Pangle AK, Johnson LG, Dranoff JA. Pathological changes in pulmonary circulation in carbon tetrachloride (CCl4)-induced cirrhotic mice. PLoS One. 2014; 9(4):e96043. PMID: 24763616.
      View in: PubMed
    24. Deneke MG, Dranoff JA, Duarte-Rojo A. [Successful eradication of genotype 4 HCV with telaprevir-based triple antiviral therapy]. Rev Gastroenterol Mex. 2014 Jan-Mar; 79(1):64-6. PMID: 24679642.
      View in: PubMed
    25. Dranoff JA, Bhatia N, Fausther M, Lavoie EG, Granell S, Baldini G, Hickman DA, Sheung N. Posttranslational regulation of tissue inhibitor of metalloproteinase-1 by calcium-dependent vesicular exocytosis. Physiol Rep. 2013 Nov; 1(6):e00125. PMID: 24400134.
      View in: PubMed
    26. Fausther M, Lavoie EG, Dranoff JA. Contribution of Myofibroblasts of Different Origins to Liver Fibrosis. Curr Pathobiol Rep. 2013 Sep; 1(3):225-230. PMID: 23997993.
      View in: PubMed
    27. Saiman Y, Agarwal R, Hickman DA, Fausther M, El-Shamy A, Dranoff JA, Friedman SL, Bansal MB. CXCL12 induces hepatic stellate cell contraction through a calcium-independent pathway. Am J Physiol Gastrointest Liver Physiol. 2013 Sep 01; 305(5):G375-82. PMID: 23812037.
      View in: PubMed
    28. Syal G, Fausther M, Dranoff JA. Advances in cholangiocyte immunobiology. Am J Physiol Gastrointest Liver Physiol. 2012 Nov 15; 303(10):G1077-86. PMID: 22961800.
      View in: PubMed
    29. Fausther M, Sheung N, Saiman Y, Bansal MB, Dranoff JA. Activated hepatic stellate cells upregulate transcription of ecto-5'-nucleotidase/CD73 via specific SP1 and SMAD promoter elements. Am J Physiol Gastrointest Liver Physiol. 2012 Oct 15; 303(8):G904-14. PMID: 22899823.
      View in: PubMed
    30. Fausther M, Gonzales E, Dranoff JA. Role of purinergic P2X receptors in the control of liver homeostasis. Wiley Interdiscip Rev Membr Transp Signal. 2012; 1(3):341 - 348.
    31. Fausther M, Gonzales E, Dranoff JA. Role of purinergic P2X receptors in the control of liver homeostasis. Wiley Interdiscip Rev Membr Transp Signal. 2012 May; 1(3):341-348. PMID: 22662313.
      View in: PubMed
    32. Fausther M, Lecka J, Soliman E, Kauffenstein G, Pelletier J, Sheung N, Dranoff JA, Sévigny J. Coexpression of ecto-5'-nucleotidase/CD73 with specific NTPDases differentially regulates adenosine formation in the rat liver. Am J Physiol Gastrointest Liver Physiol. 2012 Feb 15; 302(4):G447-59. PMID: 22135310.
      View in: PubMed
    33. Fausther M, Dranoff JA. New insights on the pathogenesis of biliary cirrhosis provided by studies in FXR knockout mice. J Hepatol. 2011 Oct; 55(4):939-40. PMID: 21672564.
      View in: PubMed
    34. Dranoff JA, Wells RG. Portal fibroblasts: Underappreciated mediators of biliary fibrosis. Hepatology. 2010 Apr; 51(4):1438-44. PMID: 20209607.
      View in: PubMed
    35. Yu J, Sheung N, Soliman EM, Spirli C, Dranoff JA. Transcriptional regulation of IL-6 in bile duct epithelia by extracellular ATP. Am J Physiol Gastrointest Liver Physiol. 2009 Mar; 296(3):G563-71. PMID: 19136380.
      View in: PubMed
    36. Soliman EM, Rodrigues MA, Gomes DA, Sheung N, Yu J, Amaya MJ, Nathanson MH, Dranoff JA. Intracellular calcium signals regulate growth of hepatic stellate cells via specific effects on cell cycle progression. Cell Calcium. 2009 Mar; 45(3):284-92. PMID: 19131107.
      View in: PubMed
    37. Sohail MA, Hashmi AZ, Hakim W, Watanabe A, Zipprich A, Groszmann RJ, Dranoff JA, Torok NJ, Mehal WZ. Adenosine induces loss of actin stress fibers and inhibits contraction in hepatic stellate cells via Rho inhibition. Hepatology. 2009 Jan; 49(1):185-94. PMID: 18844235.
      View in: PubMed
    38. SOLIMAN EM, ROGRIGUES M, GOMES DA, SHEUNG N, YU J, AMAYA MJ, NATHANSON MH, DRANOFF JA, DRANOFF. Intracellular calcium signals regulate growth of hepatic stellate cells via specific effecs on cell cycle progression. Cell Calcium. 2009; 45:284-292.
    39. Yu J, Lavoie EG, Sheung N, Tremblay JJ, Sévigny J, Dranoff JA. IL-6 downregulates transcription of NTPDase2 via specific promoter elements. Am J Physiol Gastrointest Liver Physiol. 2008 Mar; 294(3):G748-56. PMID: 18202114.
      View in: PubMed
    40. Dranoff JA, Kruglov EA, Abreu-Lanfranco O, Nguyen T, Arora G, Aurora G, Jain D. Prevention of liver fibrosis by the purinoceptor antagonist pyridoxal-phosphate-6-azophenyl-2',4'-disulfonate (PPADS). In Vivo. 2007 Nov-Dec; 21(6):957-65. PMID: 18210741.
      View in: PubMed
    41. Li Z, Dranoff JA, Chan EP, Uemura M, Sévigny J, Wells RG. Transforming growth factor-beta and substrate stiffness regulate portal fibroblast activation in culture. Hepatology. 2007 Oct; 46(4):1246-56. PMID: 17625791.
      View in: PubMed
    42. Correa PR, Kruglov EA, Thompson M, Leite MF, Dranoff JA, Nathanson MH. Succinate is a paracrine signal for liver damage. J Hepatol. 2007 Aug; 47(2):262-9. PMID: 17451837.
      View in: PubMed
    43. Hernandez E, Leite MF, Guerra MT, Kruglov EA, Bruna-Romero O, Rodrigues MA, Gomes DA, Giordano FJ, Dranoff JA, Nathanson MH. The spatial distribution of inositol 1,4,5-trisphosphate receptor isoforms shapes Ca2+ waves. J Biol Chem. 2007 Mar 30; 282(13):10057-10067. PMID: 17284437.
      View in: PubMed
    44. Kruglov EA, Correa PR, Arora G, Yu J, Nathanson MH, Dranoff JA. Molecular basis for calcium signaling in hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 2007 Apr; 292(4):G975-82. PMID: 17204544.
      View in: PubMed
    45. LI Z, DRANOF JA, CHAN EP, UEMURA M, SEVIGNY J, WELLS RG. TGF-beta and substrate stiffness regulate portal fibroblast actication in culture. HEPATOLOGY. 2007; 46:1246-56.
    46. DRANOFF JA, KRUGLOV EA, ABERU-LANFRANCO O, NGUYEN T, ARORA G, JAIN D, DRANOFF. Prevention of liver fibrosis by the purinoceptoi antagonist pyridoxalphosphate-6-azophenyl-2, 4-disulfonate (PPADS). In vivo. 2007; 21:3-11.
    47. FAUSTER M, LECKA J, KUKULSKI F, LEVESQUE S, PELLETIER J, ZIMMERMANN H, DRANOFF JA, SEVIGNY J. Cloning, Purification and identification of the liver canalicilar ecto-ATPase as NTPDase 8. Am. J. Physiol. 2007; 292:G785-95.
    48. KRUGLOV EA, CORREA P, ARORA G, NATHANSON MH, DRANOFF JA, DRANOFF. Moecular basis for calcium signaling in hepatic cells. Am. J. Physiol. 2007; 292:G975-82.
    49. HERNANDEZ E, LEITE MF, GUERRA MT, KRUGLOV EA, BRUNA-ROMERO O, RODRIGUES MA, GOMES DA, GIORDANO FJ, DRANOFF JA, NATHANSON MH. The Spacial Distribution of Inositol 1, 4, 5-Trisphosphate Receptor Isoforms Shapes Ca2+ Waves. J. BIOL. CHEM. 2007; 282:10057-67.
    50. Fausther M, Lecka J, Kukulski F, Lévesque SA, Pelletier J, Zimmermann H, Dranoff JA, Sévigny J. Cloning, purification, and identification of the liver canalicular ecto-ATPase as NTPDase8. Am J Physiol Gastrointest Liver Physiol. 2007 Mar; 292(3):G785-95. PMID: 17095758.
      View in: PubMed
    51. Hashmi AZ, Hakim W, Kruglov EA, Watanabe A, Watkins W, Dranoff JA, Mehal WZ. Adenosine inhibits cytosolic calcium signals and chemotaxis in hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 2007 Jan; 292(1):G395-401. PMID: 17053161.
      View in: PubMed
    52. KRUGLOV EA, NATHANSON RA, NGUYEN T, DRANOFF JA. Secretion of MCP-1/CCL2 by bile duct epthelia inducese myofibroblastic transdifferentiation of portal fibriblasts. Am. J. Physiol. 2006; 290:G765-71.
    53. Kruglov EA, Nathanson RA, Nguyen T, Dranoff JA. Secretion of MCP-1/CCL2 by bile duct epithelia induces myofibroblastic transdifferentiation of portal fibroblasts. Am J Physiol Gastrointest Liver Physiol. 2006 Apr; 290(4):G765-71. PMID: 16282363.
      View in: PubMed
    54. Minagawa N, Kruglov EA, Dranoff JA, Robert ME, Gores GJ, Nathanson MH. The anti-apoptotic protein Mcl-1 inhibits mitochondrial Ca2+ signals. J Biol Chem. 2005 Sep 30; 280(39):33637-44. PMID: 16027162.
      View in: PubMed
    55. Jhandier MN, Kruglov EA, Lavoie EG, Sévigny J, Dranoff JA. Portal fibroblasts regulate the proliferation of bile duct epithelia via expression of NTPDase2. J Biol Chem. 2005 Jun 17; 280(24):22986-92. PMID: 15799977.
      View in: PubMed
    56. JHANDIER MN, KRUGLOV EA, LAVOIE EG, SEVIGNY J, DRANOFF JA. Portal Fibroblasts regulate the prolferation of Buile Duct Epithelia via Expression of NTPDase2. J. BIOL. CHEM. 2005; 280:22986-96.
    57. MINAGAWA N, KRUGLOV EA, DRANOFF JA, ROBERT M, GORES G, NATHANSON MH. The anti-apoptotic protein Mcl-1 inhibits mitichindrual Ca2+ signals. J. BIOL. CHEM. 2005; 280(280):33637-44.
    58. Dranoff JA, Kruglov EA, Toure J, Braun N, Zimmermann H, Jain D, Knowles AF, Sévigny J. Ectonucleotidase NTPDase2 is selectively down-regulated in biliary cirrhosis. J Investig Med. 2004 Nov; 52(7):475-82. PMID: 15651265.
      View in: PubMed
    59. Wells RG, Kruglov E, Dranoff JA. Autocrine release of TGF-beta by portal fibroblasts regulates cell growth. FEBS Lett. 2004 Feb 13; 559(1-3):107-10. PMID: 14960316.
      View in: PubMed
    60. Dranoff JA, Ogawa M, Kruglov EA, Gaça MD, Sévigny J, Robson SC, Wells RG. Expression of P2Y nucleotide receptors and ectonucleotidases in quiescent and activated rat hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 2004 Aug; 287(2):G417-24. PMID: 14764443.
      View in: PubMed
    61. DRANOFF, JA, OGAWA M, KRULOV EA, GACA MD, SEVIGNY J, ROBSON SC, WELLS RG. Expression of P2Y Nucleotide receptors and Ecto-Nucleotidases in Quiescent and Activated Hepatice Stellate Cells. Am. J. Physiol. 2004; 287(287):G417-24.
    62. DRANOFF JA, KRUGLOVE EA, TOURE J, BRAUN N, ZIMMERMANN, JAIN D, KNOWLES AF, SEVIGNY J. The Ectonucleotidase NTPDase2 is Selectively Down-Regulated in Biliary Fibrosis. J. INVEST.MED. 2004; 52:475-82.
    63. Dranoff JA, Kruglov EA, Robson SC, Braun N, Zimmermann H, Sévigny J. The ecto-nucleoside triphosphate diphosphohydrolase NTPDase2/CD39L1 is expressed in a novel functional compartment within the liver. Hepatology. 2002 Nov; 36(5):1135-44. PMID: 12395323.
      View in: PubMed
    64. Kruglov EA, Jain D, Dranoff JA. Isolation of primary rat liver fibroblasts. J Investig Med. 2002 May; 50(3):179-84. PMID: 12033282.
      View in: PubMed
    65. Hirata K, Pusl T, O'Neill AF, Dranoff JA, Nathanson MH. The type II inositol 1,4,5-trisphosphate receptor can trigger Ca2+ waves in rat hepatocytes. Gastroenterology. 2002 Apr; 122(4):1088-100. PMID: 11910359.
      View in: PubMed
    66. KRUGLOV EA, JAIN D, DRANOFF JA, NSTHANSON MH. ISOLATION OF PRIMARY RATE LIVER FIBROBLASTS. J. INVEST.MED. 2002; 50(50):179-84.
    67. Hirata, K, Pusl, T, O'Neil, AF, Dranoff, J, Nathanson MH. The type II inositol 3,4,5-triphosphate receptor can trigger Ca2+ waves in hepatocytes. Gastroenterol. 2002; 122:1088-1100.
    68. DRANOFF JA, KRUGLOV EV, ROBSON SC, BRUAN N, ZIMMERMANN H, SEVIGNY J. THE NUCELOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE NTPDASE2/CD39L1 IS LOCALIZED TO A NOVEL COMPARTMENT WITHIN THE LIVER. HEPATOLOGY. 2002; 36(36):1135-44.
    69. Dranoff JA, Masyuk AI, Kruglov EA, LaRusso NF, Nathanson MH. Polarized expression and function of P2Y ATP receptors in rat bile duct epithelia. Am J Physiol Gastrointest Liver Physiol. 2001 Oct; 281(4):G1059-67. PMID: 11557527.
      View in: PubMed
    70. DRANOFF, J, MASYUK, AL, LARUSSO NF, NATHANSON, MH. POLARIZED EXPRESSION AND FUNCTION OF P2Y AT[ RECEPTORS IN RAT BILE DUCT EPITHELIA. Am. J. Physiol. 2001; 281:G1059-67.
    71. Dranoff JA, O'Neill AF, Franco AM, Cai SY, Connolly GC, Ballatori N, Boyer JL, Nathanson MH. A primitive ATP receptor from the little skate Raja erinacea. J Biol Chem. 2000 Sep 29; 275(39):30701-6. PMID: 10900200.
      View in: PubMed
    72. Dranoff JA, Nathanson MH. It's swell to have ATP in the liver. J Hepatol. 2000 Aug; 33(2):323-5. PMID: 10952251.
      View in: PubMed
    73. Dranoff JA, Angood PJ, Topazian M. Transnasal endoscopy for enteral feeding tube placement in critically ill patients. Am J Gastroenterol. 1999 Oct; 94(10):2902-4. PMID: 10520841.
      View in: PubMed
    74. Dranoff JA, McClure M, Burgstahler AD, Denson LA, Crawford AR, Crawford JM, Karpen SJ, Nathanson MH. Short-term regulation of bile acid uptake by microfilament-dependent translocation of rat ntcp to the plasma membrane. Hepatology. 1999 Jul; 30(1):223-9. PMID: 10385660.
      View in: PubMed
    75. Dranoff JA, Nathanson MH. Regulation of bile acid transport: beyond molecular cloning. Hepatology. 1999 Jun; 29(6):1912-3. PMID: 10347140.
      View in: PubMed
    76. Leite MF, Dranoff JA, Gao L, Nathanson MH. Expression and subcellular localization of the ryanodine receptor in rat pancreatic acinar cells. Biochem J. 1999 Jan 15; 337 ( Pt 2):305-9. PMID: 9882629.
      View in: PubMed
    77. LEITE MF, DRANOFF JA, GAO L, NATHANSON MH. EXPRESSION AND SUBCELLUAL LOCALIZATION OF RYANODINE RECEPTOR IN RAT PANCREATIC ACINAR CELLS. BIOCHEM. 1999; 337:305-9.
    78. DRANOFF JA, MCCLURE M, DENSON LA, CRAWFORD AR, CRAWFORD JM, KARPEN SJ, MATHANSON MH. SHORT-TERM REGULATION OF BILE ACID UPTAKEBY MICROFILAMENT-DEPENDENT TRANSLOCATION OF NTCP TO THE PLASMA MEMBRANE. HEPATOLOGY. 1999; 30:223-9.
    79. DRANOFF JA, ANGOOD PJ, TOPAZIAN M. TRANSNASAL ENDOSCOPY FOR ENTERAL FEEDING TUVE PLACEMENT IN CRITICALLY ILL PATIENTS. Am J Gastroenterol. 1999; 94:2902-4.
    80. Nathanson MH, Burgstahler AD, Mennone A, Dranoff JA, Rios-Velez L. Stimulation of bile duct epithelial secretion by glybenclamide in normal and cholestatic rat liver. J Clin Invest. 1998 Jun 15; 101(12):2665-76. PMID: 9637700.
      View in: PubMed
    81. NATHANSON MH, BURGSTAHLER AD, MENNONE A, DRANOFF JA, ROIS-VELEZ L. STIMULATION OF BILE DUCT EPHITHELIAL SECRETION BY GLYBENCLAMIDE IN NORMAL AND CHOLESTACTIC RAT LIVER. J. CLIN INVEST. 1998; 101:2665-2676.
    82. DRANOFF, Golbe LI, Liu JCS, Stern MB. Premorbid dietary factors in young-onset Parkinson's disease. 2nd International Congress of Movement Disorders. 1992.
    83. DRANOFF, Angood PJ, Topazian M. TRANSNASAL ENDOSCOPY FOR ENTERAL FEEDING TUVE PLACEMENT IN CRITICALLY ILL PATIENTS.
    Dranoff's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (313) concept(s)
    _
    Co-Authors Expand Description
    See all (11) people
    _
    Similar People Expand Description
    See all (26) people
    _
    Same Department Expand Description
    Search Department
    Physical Neighbors Expand Description
    _